Enrichment of Human Embryonic Stem Cell-Derived NKX6.1-Expressing Pancreatic Progenitor Cells Accelerates the Maturation of Insulin-Secreting Cells In Vivo

被引:204
作者
Rezania, Alireza [1 ]
Bruin, Jennifer E. [2 ]
Xu, Jean [1 ]
Narayan, Kavitha [1 ]
Fox, Jessica K. [2 ]
O'Neil, John J. [1 ]
Kieffer, Timothy J. [2 ,3 ]
机构
[1] Janssen R&D LLC, BetaLog Venture, Raritan, NJ USA
[2] Univ British Columbia, Lab Mol & Cellular Med, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada
[3] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada
基金
加拿大健康研究院;
关键词
Diabetes; Beta cells; Human embryonic stem cells; Cell therapy; Transplantation; ISLET TRANSPLANTATION; BETA-CELLS; GLUCOSE-TRANSPORTER; MICE; GENERATION; MAFA; DIFFERENTIATION; EXPRESSION;
D O I
10.1002/stem.1489
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Human embryonic stem cells (hESCs) are considered a potential alternative to cadaveric islets as a source of transplantable cells for treating patients with diabetes. We previously described a differentiation protocol to generate pancreatic progenitor cells from hESCs, composed of mainly pancreatic endoderm (PDX1/NKX6.1-positive), endocrine precursors (NKX2.2/synaptophysin-positive, hormone/NKX6.1-negative), and polyhormonal cells (insulin/glucagon-positive, NKX6.1-negative). However, the relative contributions of NKX6.1-negative versus NKX6.1-positive cell fractions to the maturation of functional -cells remained unclear. To address this question, we generated two distinct pancreatic progenitor cell populations using modified differentiation protocols. Prior to transplant, both populations contained a high proportion of PDX1-expressing cells (approximate to 85%-90%) but were distinguished by their relatively high (approximate to 80%) or low (approximate to 25%) expression of NKX6.1. NKX6.1-high and NKX6.1-low progenitor populations were transplanted subcutaneously within macroencapsulation devices into diabetic mice. Mice transplanted with NKX6.1-low cells remained hyperglycemic throughout the 5-month post-transplant period whereas diabetes was reversed in NKX6.1-high recipients within 3 months. Fasting human C-peptide levels were similar between groups throughout the study, but only NKX6.1-high grafts displayed robust meal-, glucose- and arginine-responsive insulin secretion as early as 3 months post-transplant. NKX6.1-low recipients displayed elevated fasting glucagon levels. Theracyte devices from both groups contained almost exclusively pancreatic endocrine tissue, but NKX6.1-high grafts contained a greater proportion of insulin-positive and somatostatin-positive cells, whereas NKX6.1-low grafts contained mainly glucagon-expressing cells. Insulin-positive cells in NKX6.1-high, but not NKX6.1-low grafts expressed nuclear MAFA. Collectively, this study demonstrates that a pancreatic endoderm-enriched population can mature into highly functional -cells with only a minor contribution from the endocrine subpopulation. Stem Cells2013;31:2432-2442
引用
收藏
页码:2432 / 2442
页数:11
相关论文
共 34 条
  • [1] Mafa expression enhances glucose-responsive insulin secretion in neonatal rat beta cells
    Aguayo-Mazzucato, C.
    Koh, A.
    El Khattabi, I.
    Li, W. -C.
    Toschi, E.
    Jermendy, A.
    Juhl, K.
    Mao, K.
    Weir, G. C.
    Sharma, A.
    Bonner-Weir, S.
    [J]. DIABETOLOGIA, 2011, 54 (03) : 583 - 593
  • [2] The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells
    Basford, C. L.
    Prentice, K. J.
    Hardy, A. B.
    Sarangi, F.
    Micallef, S. J.
    Li, X.
    Guo, Q.
    Elefanty, A. G.
    Stanley, E. G.
    Keller, G.
    Allister, E. M.
    Nostro, M. C.
    Wheeler, M. B.
    [J]. DIABETOLOGIA, 2012, 55 (02) : 358 - 371
  • [3] NEOVASCULARIZATION OF SYNTHETIC MEMBRANES DIRECTED BY MEMBRANE MICROARCHITECTURE
    BRAUKER, JH
    CARRBRENDEL, VE
    MARTINSON, LA
    CRUDELE, J
    JOHNSTON, WD
    JOHNSON, RC
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1995, 29 (12): : 1517 - 1524
  • [4] Bruin JE, 2012, STEM CELLS CANC STEM, P192
  • [5] Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice
    Bruin, Jennifer E.
    Rezania, Alireza
    Xu, Jean
    Narayan, Kavitha
    Fox, Jessica K.
    O'Neil, John J.
    Kieffer, Timothy J.
    [J]. DIABETOLOGIA, 2013, 56 (09) : 1987 - 1998
  • [6] Beta cell nuclear musculoaponeurotic fibrosarcoma oncogene family A (MafA) is deficient in type 2 diabetes
    Butler, A. E.
    Robertson, R. P.
    Hernandez, R.
    Matveyenko, A. V.
    Gurlo, T.
    Butler, P. C.
    [J]. DIABETOLOGIA, 2012, 55 (11) : 2985 - 2988
  • [7] Generation of Homogeneous PDX1+ Pancreatic Progenitors from Human ES Cell-derived Endoderm Cells
    Cai, Jun
    Yu, Chen
    Liu, Yanxia
    Chen, Song
    Guo, Yuxuan
    Yong, Jun
    Lu, Wei
    Ding, Mingxiao
    Deng, Hongkui
    [J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2010, 2 (01) : 50 - 60
  • [8] Persistent glucose transporter expression on pancreatic beta cells from longstanding type 1 diabetic individuals
    Coppieters, Ken T.
    Wiberg, Anna
    Amirian, Natalie
    Kay, Thomas W.
    von Herrath, Matthias G.
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (08) : 746 - 754
  • [9] Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells
    D'Amour, Kevin A.
    Bang, Anne G.
    Eliazer, Susan
    Kelly, Olivia G.
    Agulnick, Alan D.
    Smart, Nora G.
    Moorman, Mark A.
    Kroon, Evert
    Carpenter, Melissa K.
    Baetge, Emmanuel E.
    [J]. NATURE BIOTECHNOLOGY, 2006, 24 (11) : 1392 - 1401
  • [10] HUMAN AND RAT BETA-CELLS DIFFER IN GLUCOSE-TRANSPORTER BUT NOT IN GLUCOKINASE GENE-EXPRESSION
    DEVOS, A
    HEIMBERG, H
    QUARTIER, E
    HUYPENS, P
    BOUWENS, L
    PIPELEERS, D
    SCHUIT, F
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) : 2489 - 2495